110 related articles for article (PubMed ID: 2095392)
1. Epidemiology of cardiovascular disease in developing countries.
Akinkugbe OO
J Hypertens Suppl; 1990 Dec; 8(7):S233-8. PubMed ID: 2095392
[TBL] [Abstract][Full Text] [Related]
2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
3. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
4. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular emergencies in Subsaharan Africa].
Bertrand E; Muna WF; Diouf SM; Ekra A; Kane A; Kingue S; Kombila P; Mbaissoroum M; Niakara A; Ould Eba A; Sidi Al AO; Yapobi Y;
Arch Mal Coeur Vaiss; 2006 Dec; 99(12):1159-65. PubMed ID: 18942515
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular mortality in industrial and developing countries (author's transl)].
Garros B; Cantrelle P; Hatton F
Rev Epidemiol Sante Publique; 1980 Apr; 28(1):69-79. PubMed ID: 6451007
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive agents and cardiovascular risk factors.
Fodor JG
Clin Ther; 1986; 8(5):490-509. PubMed ID: 2876774
[TBL] [Abstract][Full Text] [Related]
9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
10. The limits of antihypertensive therapy--lessons from Third World to First.
Seedat YK
Cardiovasc J S Afr; 2001; 12(2):94-100. PubMed ID: 11447498
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular diseases in the eastern Mediterranean region.
Alwan AA
World Health Stat Q; 1993; 46(2):97-100. PubMed ID: 8303910
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition in clinical practice. Re-examination of step care: choice of first drug.
Breckenridge A
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S117-20. PubMed ID: 2580163
[TBL] [Abstract][Full Text] [Related]
13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
14. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
[TBL] [Abstract][Full Text] [Related]
15. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
Zanchetti A
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
[TBL] [Abstract][Full Text] [Related]
18. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
19. The global impact of noncommunicable diseases: estimates and projections.
Manton KG
World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
